Gender differences in utilization of preventive care services in the United States V Vaidya, G Partha, M Karmakar Journal of women's health 21 (2), 140-145, 2012 | 418 | 2012 |
Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review V Vaidya, N Gangan, J Sheehan Expert review of pharmacoeconomics & outcomes research 15 (3), 487-497, 2015 | 145 | 2015 |
A mixed-methods analysis in assessing students’ professional development by applying an assessment for learning approach MJ Peeters, VA Vaidya American Journal of Pharmaceutical Education 80 (5), 77, 2016 | 38 | 2016 |
Utilization of preventive care services and their effect on cardiovascular outcomes in the United States V Vaidya, G Partha, J Howe Risk Management and Healthcare Policy, 1-7, 2011 | 35 | 2011 |
Clinical outcomes and cost-effectiveness of initial treatment strategies for nonembolic acute limb ischemia in real-life clinical settings F Lurie, V Vaidya, AJ Comerota Journal of Vascular Surgery 61 (1), 138-146, 2015 | 32 | 2015 |
Determining patient preferences of community pharmacy attributes: a systematic review PM Patel, V Vaidya, F Osundina, DA Comoe Journal of the American Pharmacists Association 60 (2), 397-404, 2020 | 25 | 2020 |
An international capstone experience for pharmacy students DR Gourley, VA Vaidya, MA Hufstader, MD Ray, MA Chisholm-Burns American Journal of Pharmaceutical Education 77 (3), 50, 2013 | 25 | 2013 |
Cost burden of the ‘presenteeism’ health outcome in a diverse nurse and pharmacist workforce: Practice models and health policy implications CL Warren The University of Tennessee Health Science Center, 2009 | 23 | 2009 |
Conjoint analysis of patient preferences on Medicare medication therapy management SH Hong, J Liu, J Wang, L Brown, S White-Means Journal of the American Pharmacists Association 51 (3), 378-387, 2011 | 22 | 2011 |
Utilization of smoking-cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients V Vaidya, M Hufstader-Gabriel, N Gangan, S Shah, R Bechtol Current medical research and opinion 30 (6), 1043-1050, 2014 | 20 | 2014 |
Emerging and encouraging trends in e-prescribing adoption among providers and pharmacies. ME Gabriel, MF Furukawa, V Vaidya The American Journal of Managed Care 19 (9), 760-764, 2013 | 20 | 2013 |
Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia MF Alsaqa’aby, V Vaidya, N Khreis, T Al Khairallah, AH Al-Jedai Annals of Saudi medicine 37 (6), 433-443, 2017 | 17 | 2017 |
Failure to refill essential prescription medications for asthma among pediatric Medicaid beneficiaries with persistent asthma V Vaidya, R Gupte, R Balkrishnan Patient preference and adherence, 21-26, 2013 | 15 | 2013 |
The impact of patient knowledge of patient-centered medication label content on quality of life among older adults SH Hong, J Liu, S Tak, V Vaidya Research in Social and Administrative pharmacy 9 (1), 37-48, 2013 | 15 | 2013 |
Pharmacists’ perceived barriers providing non-dispensing services to underserved populations L Blazejewski, V Vaidya, S Pinto, C Gaither Journal of community health 38, 812-822, 2013 | 14 | 2013 |
Cost-effectiveness analysis of initial treatment strategies for nonembolic acute limb ischemia using real-word data V Vaidya, N Gangan, A Comerota, F Lurie Annals of Vascular Surgery 39, 276-283, 2017 | 12 | 2017 |
Adoption of electronic prescribing for controlled substances among providers and pharmacies. Y Yang, V Vaidya, TL Wilkins The American Journal of Managed Care 20 (11 Spec No. 17), SP541-6, 2014 | 12 | 2014 |
Demographic disparities in patient-reported use of inhaled corticosteroids among patients with persistent asthma V Vaidya, M Holiday-Goodman, S Pinto Journal of asthma and allergy, 101-106, 2010 | 11 | 2010 |
Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real … JA Scott, J Lennerz, ML Johnson, LN Gordan, RH Dumanois, L Quagliata, ... JCO oncology practice 20 (1), 145-153, 2024 | 8 | 2024 |
Evaluation of outcomes in patients (pts) with stage 4 non-small cell lung cancer (NSCLC 4) harboring actionable oncogenic drivers (AOD) when treated prior to report of mutation … RE Smith, ML Johnson, LN Gordan, M Xue, P Varughese, NA Dorrow, ... Journal of Clinical Oncology 40 (16_suppl), 1530-1530, 2022 | 8 | 2022 |